BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 30971443)

  • 1. A Cohort Study of the Impact of Carbapenem-Resistant
    Sabino S; Soares S; Ramos F; Moretti M; Zavascki AP; Rigatto MH
    mSphere; 2019 Apr; 4(2):. PubMed ID: 30971443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital.
    Li C; Li Y; Zhao Z; Liu Q; Li B
    J Infect Public Health; 2019; 12(1):26-31. PubMed ID: 30145151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
    Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D
    J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis.
    Zilberberg MD; Nathanson BH; Sulham K; Fan W; Shorr AF
    BMC Infect Dis; 2017 Apr; 17(1):279. PubMed ID: 28415969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae.
    Freire MP; de Oliveira Garcia D; Cury AP; Francisco GR; Dos Santos NF; Spadão F; Bueno MFC; Camargo CH; de Paula FJ; Rossi F; Nahas WC; David-Neto E; Pierrotti LC
    Eur J Clin Microbiol Infect Dis; 2019 Apr; 38(4):755-765. PubMed ID: 30680569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteremic Urinary Tract Infection Caused by Multidrug-Resistant Enterobacteriaceae Are Associated With Severe Sepsis at Admission: Implication for Empirical Therapy.
    Lee YC; Hsiao CY; Hung MC; Hung SC; Wang HP; Huang YJ; Wang JT
    Medicine (Baltimore); 2016 May; 95(20):e3694. PubMed ID: 27196480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective Observational Study from a Chinese Network of the Impact of Combination Therapy versus Monotherapy on Mortality from Carbapenem-Resistant
    Wang X; Wang Q; Cao B; Sun S; Zhang Y; Gu B; Li B; Liao K; Zhao F; Jin L; Jin C; Yang C; Pei F; Zhang Z; Wang H
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.
    Russo A; Falcone M; Gutiérrez-Gutiérrez B; Calbo E; Almirante B; Viale PL; Oliver A; Ruiz-Garbajosa P; Gasch O; Gozalo M; Pitout J; Akova M; Peña C; Cisneros JM; Hernández-Torres A; Farcomeni A; Prim N; Origüen J; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Karaiskos I; de la Calle C; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Mora-Rillo M; Rodriguez-Gomez J; Souli M; Bonomo RA; Paterson DL; Carmeli Y; Pascual A; Rodríguez-Baño J; Venditti M;
    Int J Antimicrob Agents; 2018 Nov; 52(5):577-585. PubMed ID: 29969692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbapenem-resistant Enterobacteriaceae: A retrospective review of treatment and outcomes in a long-term acute care hospital.
    Igbinosa O; Dogho P; Osadiaye N
    Am J Infect Control; 2020 Jan; 48(1):7-12. PubMed ID: 31431290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with mortality in Infections caused by Carbapenem-resistant Enterobacteriaceae.
    Gualtero S; Valderrama S; Valencia M; Rueda D; Muñoz-Velandia O; Ariza B; Cortes G; Salgado D; Porras Y; Niño A
    J Infect Dev Ctries; 2020 Jun; 14(6):654-659. PubMed ID: 32683357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of carbapenem resistance on clinical deterioration and mortality in patients with liver disease.
    Ferstl PG; Filmann N; Brandt C; Zeuzem S; Hogardt M; Kempf VAJ; Müller M; Waidmann O; Reinheimer C
    Liver Int; 2017 Oct; 37(10):1488-1496. PubMed ID: 28374901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sepsis 2019: What Surgeons Need to Know.
    Ho VP; Kaafarani H; Rattan R; Namias N; Evans H; Zakrison TL
    Surg Infect (Larchmt); 2020 Apr; 21(3):195-204. PubMed ID: 31755816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. qSOFA score: Predictive validity in Enterobacteriaceae bloodstream infections.
    Burnham JP; Kollef MH
    J Crit Care; 2018 Feb; 43():143-147. PubMed ID: 28898743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae.
    Alraddadi BM; Saeedi M; Qutub M; Alshukairi A; Hassanien A; Wali G
    BMC Infect Dis; 2019 Sep; 19(1):772. PubMed ID: 31484510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock.
    Vazquez-Guillamet C; Scolari M; Zilberberg MD; Shorr AF; Micek ST; Kollef M
    Crit Care Med; 2014 Nov; 42(11):2342-9. PubMed ID: 25072764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
    Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
    Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Sepsis Classification and Multidrug-Resistance Status on Outcome Among Patients Treated With Appropriate Therapy.
    Burnham JP; Lane MA; Kollef MH
    Crit Care Med; 2015 Aug; 43(8):1580-6. PubMed ID: 25855900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of sepsis in intensive care units in Turkey: a multicenter, point-prevalence study.
    Baykara N; Akalın H; Arslantaş MK; Hancı V; Çağlayan Ç; Kahveci F; Demirağ K; Baydemir C; Ünal N;
    Crit Care; 2018 Apr; 22(1):93. PubMed ID: 29656714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and risk factors for neonatal bloodstream infection due to carbapenem-resistant Enterobacteriaceae: A single-centre Chinese retrospective study.
    Fang P; Gao K; Yang J; Li T; Sun Q; Shan Z; Wang Y
    J Glob Antimicrob Resist; 2024 Jun; 37():28-36. PubMed ID: 38412919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.